SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-038470
Filing Date
2021-02-11
Accepted
2021-02-11 16:16:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d78136dsc13g.htm SC 13G 38510
  Complete submission text file 0001193125-21-038470.txt   39833
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91770 | Film No.: 21619873
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALIGOS THERAPEUTICS, INC. ONE CORPORATE DRIVE, 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Beigelman Leonid (Filed by) CIK: 0001824721 (see all company filings)

Type: SC 13G